Valsartan reduces serum cystatin C and the renal vascular resistance in patients with essential hypertension. [electronic resource]
Producer: 20061212Description: 451-61 p. digitalISSN:- 1064-1963
- Adult
- Aged
- Albuminuria -- drug therapy
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Antihypertensive Agents -- therapeutic use
- Biomarkers -- blood
- Blood Flow Velocity -- drug effects
- Blood Pressure -- drug effects
- Creatinine -- blood
- Cystatin C
- Cystatins -- blood
- Female
- Humans
- Hypertension -- drug therapy
- Japan
- Kidney -- blood supply
- Kidney Function Tests
- Male
- Middle Aged
- Prospective Studies
- Pulsatile Flow -- drug effects
- Renal Circulation -- drug effects
- Tetrazoles -- antagonists & inhibitors
- Treatment Outcome
- Ultrasonography, Doppler
- Valine -- analogs & derivatives
- Valsartan
- Vascular Resistance -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.